Oncologic efficacy of focal therapies in prostate cancer (PCa) depends heavily on accurate tumor size estimation. We aim to evaluate the agreement between radiologic tumor size (RTS) and pathologic tumor size (PTS) and identify predictors of PTS.
Oncologic efficacy of focal therapies in prostate cancer (PCa) depends heavily on accurate tumor size estimation. We aim to evaluate the agreement between radiologic tumor size (RTS) and pathologic tumor size (PTS) and identify predictors of PTS.